Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker FTH
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 600 | $24.22 | $14.5K Buy | Form 4 ↗ |
| Jul 1, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 4,400 | $23.40 | $103.0K Buy | Form 4 ↗ |
| Jun 30, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 4,255 | $24.98 | $106.3K Buy | Form 4 ↗ |
| Jun 30, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 1,638 | $23.88 | $39.1K Buy | Form 4 ↗ |
| Jun 30, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 1,910 | $22.95 | $43.8K Buy | Form 4 ↗ |
| Jun 29, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 831 | $23.34 | $19.4K Buy | Form 4 ↗ |
| Jun 26, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 100 | $26.39 | $2,639 Buy | Form 4 ↗ |
| Jun 26, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 1,358 | $25.55 | $34.7K Buy | Form 4 ↗ |
| Jun 26, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 4,212 | $24.90 | $104.9K Buy | Form 4 ↗ |
| Jun 26, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 580 | $23.61 | $13.7K Buy | Form 4 ↗ |
| Jun 24, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 100 | $27.77 | $2,777 Buy | Form 4 ↗ |
| Jun 24, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 3,400 | $26.98 | $91.7K Buy | Form 4 ↗ |
| Jun 24, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 3,000 | $25.98 | $77.9K Buy | Form 4 ↗ |
| Jun 24, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 2,891 | $25.22 | $72.9K Buy | Form 4 ↗ |
| Jun 23, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 425 | $25.91 | $11.0K Buy | Form 4 ↗ |
| Jun 23, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 1,969 | $24.84 | $48.9K Buy | Form 4 ↗ |
| Jun 23, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 6,836 | $24.12 | $164.9K Buy | Form 4 ↗ |
| Jun 22, 2026 | Anand Kiran Parikh President and CEO, Director | FTH Faeth Therapeutics, Inc. | Buy | 2,806 | $19.76 | $55.4K Buy | Form 4 ↗ |
| Jun 22, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 356 | $23.95 | $8,526 Buy | Form 4 ↗ |
| Jun 22, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 3,329 | $23.28 | $77.5K Buy | Form 4 ↗ |
| Jun 22, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 1,583 | $22.40 | $35.5K Buy | Form 4 ↗ |
| Jun 22, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 1,118 | $20.82 | $23.3K Buy | Form 4 ↗ |
| Jun 22, 2026 | Brian C. Stephenson Chief Financial Officer | FTH Faeth Therapeutics, Inc. | Buy | 1,797 | $20.23 | $36.4K Buy | Form 4 ↗ |
| Jun 1, 2026 | Cambrian BioPharma Inc 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 476 | $21.14 | $10.1K Sale | Form 4 ↗ |
| Jun 1, 2026 | Cambrian BioPharma Inc 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 24,524 | $20.00 | $490.5K Sale | Form 4 ↗ |
| Jun 1, 2026 | James Peyer 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 476 | $21.14 | $10.1K Sale | Form 4 ↗ |
| Jun 1, 2026 | James Peyer 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 24,524 | $20.00 | $490.5K Sale | Form 4 ↗ |
| Apr 7, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 1,108 | $33.38 | $37.0K Sale | Form 4 ↗ |
| Apr 7, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 300 | $32.25 | $9,675 Sale | Form 4 ↗ |
| Apr 7, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 4,423 | $31.38 | $138.8K Sale | Form 4 ↗ |
| Apr 7, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 205 | $29.71 | $6,091 Sale | Form 4 ↗ |
| Apr 7, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 2,115 | $28.94 | $61.2K Sale | Form 4 ↗ |
| Apr 7, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 1,108 | $33.38 | $37.0K Buy | Form 4 ↗ |
| Apr 6, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 45 | $31.96 | $1,438 Sale | Form 4 ↗ |
| Apr 6, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 1,214 | $31.02 | $37.7K Sale | Form 4 ↗ |
| Apr 6, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 1,104 | $31.02 | $34.2K Buy | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 1,134 | $34.80 | $39.5K Sale | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 374 | $33.35 | $12.5K Sale | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 1,794 | $32.60 | $58.5K Sale | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 1,265 | $31.75 | $40.2K Sale | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 3,099 | $30.86 | $95.6K Sale | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 701 | $35.55 | $24.9K Buy | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 1,276 | $34.75 | $44.3K Buy | Form 4 ↗ |
| Apr 2, 2026 | Ics Opportunities II LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 26 | $33.47 | $870 Buy | Form 4 ↗ |
| Apr 1, 2026 | Millennium Management LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 46 | $34.75 | $1,599 Sale | Form 4 ↗ |
| Apr 1, 2026 | Millennium Management LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 1,104 | $31.52 | $34.8K Sale | Form 4 ↗ |
| Apr 1, 2026 | Millennium Management LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 3,401 | $35.46 | $120.6K Buy | Form 4 ↗ |
| Apr 1, 2026 | Millennium Management LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 1,613 | $34.59 | $55.8K Buy | Form 4 ↗ |
| Apr 1, 2026 | Millennium Management LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Buy | 1,161 | $31.53 | $36.6K Buy | Form 4 ↗ |
| Mar 31, 2026 | Millennium Management LLC 10% owner | SNSE Faeth Therapeutics, Inc. | Sale | 87 | $31.52 | $2,742 Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:18 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances